ストックスクリーナーアプリを入手
15.88
1.08%
0.17
アフターアワーズ：
15.43
-0.45
-2.83%
Simulations Plus Inc (SLP) 最新ニュース
Simulations Plus Collaborates With Nvidia During AI Drug Modeling Push - Benzinga
Simulations Plus partners with Nvidia on AI drug development - Investing.com
Simulations Plus partners with Nvidia on AI drug development By Investing.com - Investing.com Nigeria
Simulations Plus stock surges 28% on NVIDIA collaboration - Investing.com
Simulations Plus and NVIDIA Collaborate to Scale GPU-Accelerated, AI-Assisted Modeling Workflows - Business Wire
Insider Sell Alert: DiBella John Anthony II Sells Shares of Simu - GuruFocus
[Form 4] Simulations Plus, Inc. Insider Trading Activity - Stock Titan
Simulations Plus (SLP) insiders sell 15,000 shares in planned trade - Stock Titan
Do options traders know something about Simulations Plus stock we don't? - MSN
[144] Simulations Plus, Inc. SEC Filing - Stock Titan
(SLP) as a Liquidity Pulse for Institutional Tactics - Stock Traders Daily
Do Options Traders Know Something About Simulations Plus Stock We Don't? - TradingView
Simulations Plus (SLP) director receives 2,117-share equity grant as compensation - Stock Titan
Director Sharlene Evans receives 2,117 SLP shares in equity grant - Stock Titan
Director at Simulations Plus (SLP) receives 2,117-share stock grant - Stock Titan
Simulations Plus (SLP) director awarded 2,117 shares as equity compensation - Stock Titan
SLP Stock Price, Quote & Chart | SIMULATIONS PLUS INC (NASDAQ:SLP) - ChartMill
AI in Predictive Toxicology Research Report 2026 Featuring - GlobeNewswire
AI in Predictive Toxicology Research Report 2026 Featuring Certara, Schrodinger, Instem, Simulations Plus, Lhasa, ChemaxonGlobal Forecast to 2030 and 2035 - Yahoo Finance UK
Global Biosimulation Market Poised for Phenomenal Expansion at a CAGR of ~17% by 2034 | DelveInsight - GlobeNewswire Inc.
Simulations Plus, Inc. (NASDAQ:SLP) Receives Consensus Rating of "Hold" from Brokerages - MarketBeat
Latest SLP NewsSimulations Plus Announces Quarterly Cash Di... - Stock Titan
Simulations Plus Q2 2026 earnings preview - MSN
Certara Strategic Business Divestiture Comes At Right Time, Says Analyst - Sahm
(SLP) Risk Channels and Responsive Allocation - Stock Traders Daily
Simulations Plus shares drop over 12% premarket as Q3 revenue forecast misses expectations - MSN
SLP Simulations Plus posts strong Q1 2026 results, shares rise over four percent on double digit EPS and revenue gains.Debt/Equity - Xã Thanh Hà
Simulations Plus partners with Lonza and FDA on drug formulation research - Investing.com Nigeria
Simulations Plus (SLP) Partners with FDA and Lonza for Drug Perf - GuruFocus
Simulations Plus enters funded research collaboration with Lonza, FDA - TipRanks
Simulations Plus partners with Lonza and FDA on drug formulation research By Investing.com - Investing.com South Africa
Simulations Plus Announces Collaboration with Lonza and U.S. FDA to Advance Predictive Frameworks for Complex Oral Drug Products - Business Wire
Craig-Hallum Maintains Simulations Plus(SLP.US) With Buy Rating - Moomoo
Simulations Plus (SLP) Completes Successful Spring School Traini - GuruFocus
What Happened to Simulations Plus (SLP) Stock Today (Wavering) 2026-04-20Continuation Signals - Cổng thông tin điện tử tỉnh Tây Ninh
Simulations Plus Expands Global Access to Model-Informed Drug Development Training Through Its 2026 Spring School - 01net
Simulations Plus Inc Announces Completion of 2026 Spring School Global Training Initiative - marketscreener.com
Simulations Plus Reports Strong Fiscal Second Quarter Growth - HarianBasis.co
Here’s Simulations Plus Inc (SLP)’s Vision for AI in Drug Development - Insider Monkey
Simulations Plus, Children's Place and 3 stocks to watch heading into Friday - MSN
Simulations Plus (SLP) Stock Public Float (+1.77%) 2026-04-18Continuation Pattern - Cổng thông tin điện tử tỉnh Tây Ninh
Simulations Plus, Inc. (SLP) Stock Analysis: Exploring a 67.61% Potential Upside in Healthcare Software Solutions - DirectorsTalk Interviews
Simulations Plus, Inc. (NASDAQ: SLP) Q2 2026 earnings call transcript - MSN
Insider Sell: DiBella John Anthony II Sells Shares of Simulations Plus Inc (SLP) - GuruFocus
John Anthony Dibella II Sells 1,000 Shares of Simulations Plus (NASDAQ:SLP) Stock - MarketBeat
DiBella, Simulations Plus CRO, sells $13370 in SLP stock By Investing.com - Investing.com Canada
Simulations Plus (SLP) CRO sells 1,000 shares via Rule 10b5-1 plan - Stock Titan
HTPK platform from Simulations Plus targets smarter early compound selection at DDC - Traders Union
Simulations Plus: Better Quarter, Same Doubts (NASDAQ:SLP) - Seeking Alpha
3.32%
1.24%
大文字化:
|
ボリューム (24 時間):